Michael E. Thase, MD

Articles by Michael E. Thase, MD

Remission vs. Response: Redefining Treatment Goals in Major Depressive Disorder

ByKen Cohen, MD,Samuel Wilkinson, MD,Greg Rhee, PhD, FACE,Michael E. Thase, MD,Nisha Bhide, PharmD

August 27th 2026

Major depressive disorder (MDD) is a heterogeneous disorder with many unique symptom combinations.

The Burden of Major Depressive Disorder: Setting the Stage for Managed Care

ByKen Cohen, MD,Samuel Wilkinson, MD,Greg Rhee, PhD, FACE,Michael E. Thase, MD,Nisha Bhide, PharmD

August 27th 2026

Welcome back to another AJMC Peer Exchange series. In this episode titled, "The Burden of Major Depressive Disorder: Setting the Stage for Managed Care."

Introduction

ByMichael E. Thase, MD

September 1st 2001

The Clinical, Psychosocial, and Pharmacoeconomic Ramifications of Remission

ByMichael E. Thase, MD

September 1st 2001

Latest Updated Articles

Introduction
September 1st 2001
The Clinical, Psychosocial, and Pharmacoeconomic Ramifications of Remission
September 1st 2001

Michael E. Thase, MD

Articles by Michael E. Thase, MD

Remission vs. Response: Redefining Treatment Goals in Major Depressive Disorder

The Burden of Major Depressive Disorder: Setting the Stage for Managed Care

Introduction

The Clinical, Psychosocial, and Pharmacoeconomic Ramifications of Remission

Latest Updated Articles

Trending on AJMC

DOJ Abandons Olmstead Defense as Texas v Kennedy Advances

FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes

Myasthenia Gravis Linked to Greater Longevity Than Multiple Sclerosis

FDA Approves Rusfertide to Treat Erythrocytosis In Polycythemia Vera

Unvaccinated COVID-19 Infection Tied to Higher Myocarditis Risk